Literature DB >> 32360196

Reversal of Cardiac Hypertrophy With a Ketogenic Diet in a Child With Mitochondrial Disease and Hypertrophic Cardiomyopathy.

Emilie Deberles1, Pascale Maragnes2, Marie-José Penniello-Valette3, Stéphane Allouche4, Michael Joubert5.   

Abstract

Mitochondrial diseases are rare metabolic disorders that can cause hypertrophic cardiomyopathy. Herein we describe the case of a 3-year-old girl diagnosed with mitochondrial disease (mutation m.5559A>G in the mitochondrial-tRNATrp gene). Echocardiography showed left ventricular hypertrophy with an enlarged septum (9 mm, z score = 3.26). Antioxidant supplementation associated with a high-fat ketogenic diet was introduced and, as expected, improved neurologic status. In addition, heart parameters improved with normalisation of interventricular septum thickness at 6 years of age (6 mm, z score = 1.05). In this case report, we suggest that a ketogenic diet may improve hypertrophic cardiomyopathy in the context of mitochondrial disease.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32360196     DOI: 10.1016/j.cjca.2020.04.024

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  2 in total

1.  Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21.

Authors:  Eun Ran Kim; So Ra Kim; Wonhee Cho; Sang-Guk Lee; Soo Hyun Kim; Jin Hee Kim; Eunhye Choi; Jeong-Ho Kim; Je-Wook Yu; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Myung-Shik Lee; Jin Won Cho; Justin Y Jeon; Yong-Ho Lee
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 2.  Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety.

Authors:  Heidi Zweers; Annemiek M J van Wegberg; Mirian C H Janssen; Saskia B Wortmann
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.